MILD TO MODERATE ALZHEIMER'S DISEASE

Clinical trials for MILD TO MODERATE ALZHEIMER'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new MILD TO MODERATE ALZHEIMER'S DISEASE trials appear

Sign up with your email to follow new studies for MILD TO MODERATE ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New nasal spray trial targets Alzheimer's with stem cell particles

Disease control Not yet recruiting

This early-stage study is testing the safety and initial effects of a nasal spray containing tiny particles (exosomes) from umbilical cord stem cells in people with mild to moderate Alzheimer's disease. The spray is given twice a week for 12 weeks. The study will first test incre…

Matched conditions: MILD TO MODERATE ALZHEIMER'S DISEASE

Phase: PHASE1, PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control

Last updated Apr 02, 2026 05:41 UTC

MILD TO MODERATE ALZHEIMER'S DISEASE

Get alerted when new MILD TO MODERATE ALZHEIMER'S DISEASE trials appear

New nasal spray trial targets Alzheimer's with stem cell particles